Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
United Immunity, Co., Ltd. logo — Unite the Power of Immunity and Nanoparticle, Change the Fut...

United Immunity, Co., Ltd.

Unite the Power of Immunity and Nanoparticle, Change the Future of Patients

Founded 2017 Japan Japan 14 employees Debt Financing Total: $270.00M Care Economy, Health Care +1

General Information

Company Name United Immunity, Co., Ltd.
Founded Year 2017
Location Japan Japan +2
Employees 14
Industries Care Economy, Health Care, Nutrition
Funding Stage Debt Financing
Social

Get notified when United Immunity, Co., Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About United Immunity, Co., Ltd.

United Immunity is a Japan-based startup with a compelling slogan: "Uniting Immunity and Nanotechnology to Fight Cancer." Since its founding in 2017, the company has been dedicated to revolutionizing cancer and infectious disease treatments. United Immunity's innovative approach revolves around targeting myeloid cells using groundbreaking nanoparticles and lipid nanoparticles (LNPs) based on Cholesteryl Pullulan, designed to deliver therapeutic agents to macrophages and dendritic cells selectively. This technology has broad applications, encompassing the treatment of cancer, autoimmune, fibrosis, and infectious diseases. One of the standout programs is UI-102, which leverages the company's nanoparticles to precisely deliver a Toll-like receptor (TLR) agonist to tumor-associated macrophages (TAM), aiming to transition the tumor microenvironment from "cold (immune-suppressed)" to "hot (immune-activated)." This approach not only seeks to enhance the efficacy of checkpoint inhibitors and other cancer agents but also significantly reduce the safety risks associated with TLR agonism. Furthermore, United Immunity utilizes its technology to enhance the effectiveness of T-cell therapies and generate in vivo CAR-macrophages. The startup's recent achievement includes securing a ¥180.00M Debt Financing investment on 18 March 2024, with Aozora Corporate Investment as the investor. United Immunity's ambitious vision and groundbreaking technologies position it as a promising player in the Health Care and Nutrition industries, offering potential for significant impact in the realm of cancer and infectious disease treatments.

Taxonomy: Nanotechnology, Lipid nanoparticles, Cancer immunotherapy, Myeloid cells, Macrophages, Dendritic cells, Autoimmune diseases, Fibrosis, Infectious diseases, mRNA therapeutics, Tumor microenvironment modulation, T-cell therapies, CAR-macrophages, Checkpoint inhibitors

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1
Investor
18 Mar 2024
Grant •••••• 3
Investor Investor
•••• •••• 		11 Sep 2023
Series A •••••• 1
Investor
01 Mar 2021
Corporate Round •••••• 1
Investor
08 Dec 2020
Series A •••••• 2
Investor Investor
07 Jun 2019

View All 6 Funding Rounds

United Immunity, Co., Ltd. Alternatives & Competitors

United Immunity, Co., Ltd. vs
Mosaic ImmunoEngineering Inc.
Mosaic ImmunoEngineering Inc.

Advancing novel immunostimulatory nanoparticles for the treatment and prevention of cancer and infec...

7 employees
Biotechnology, Health Care
United Immunity, Co., Ltd. vs
Repertoire Genesis Inc.
Repertoire Genesis Inc. Japan

Curing the Incurable

Corporate Round
6 employees
Biotechnology, Renewable Energy

FAQ About United Immunity, Co., Ltd.

Unite the Power of Immunity and Nanoparticle, Change the Future of Patients
United Immunity, Co., Ltd. was founded in 2017.
United Immunity, Co., Ltd. is headquartered in Japan.
United Immunity, Co., Ltd. operates in the following industries: Care Economy, Health Care, Nutrition.
United Immunity, Co., Ltd. has approximately 14 employees.
United Immunity, Co., Ltd. has completed 6 funding rounds, raising a total of $270.00M. The latest funding stage is Debt Financing.
Top alternatives and competitors to United Immunity, Co., Ltd. include Mosaic ImmunoEngineering Inc., Repertoire Genesis Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
United Immunity, Co., Ltd. and Mosaic ImmunoEngineering Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors United Immunity, Co., Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy